Tuesday, October 4, 2016

Soliris




In the US, SOLIRIS (eculizumab systemic) is a member of the drug class selective immunosuppressants and is used to treat Hemolytic Uremic Syndrome and Paroxysmal Nocturnal Hemoglobinuria.

US matches:

  • Soliris

UK matches:

  • Soliris (SPC)

Ingredient matches for SOLIRIS



Eculizumab

Eculizumab is reported as an ingredient of SOLIRIS in the following countries:


  • Austria

  • Canada

  • Denmark

  • France

  • Germany

  • Luxembourg

  • Netherlands

  • Spain

  • Sweden

  • Switzerland

  • United Kingdom

  • United States

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

No comments:

Post a Comment